Human resources professional Susan Seliga reflects on completing her master’s degree while working full-time at Columbia.

SpyGlass Pharma secures $75 million in Series D funding to enhance its innovative drug delivery platform for long-term ...

Tom Barron As president of Capital City Bank Group and chairman of the Capital City Bank Board of Directors, Tom Barron will ...

The classic hot topics of sustainability are climate-related, focusing on corporate approaches to a reduced carbon footprint ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Meriaura Group PlcCompany Announcement 30 May 2025 at 3.00 p.m. (CEST) Change in Summa Defence's Executive Management Team Summa Defence Oy's Chief Human Resources Officer and Executive Management ...

Both assets are currently being evaluated in Phase 1 clinical trials ... ARCH Ventures, B-Capital, Droia Ventures, Vida Ventures, Catalio Capital Management and Eli Lilly & Company.

First of five Phase 2 trials for AL001 ... the minimum bid price requirement of $1.00 per share required to maintain continued listing on the Nasdaq Capital Market. Price Action: At the last ...

MarshBerry’s role is to help sellers look beyond the headline number and assess what the future of the business will look ...